Does Rallies show ORKA 10-K and 10-Q filings?

Rallies organizes ORKA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is ORKA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ORKA. It does not provide personalized investment advice.

ORKA (Oruka Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Oruka Therapeutics, Inc. Common Stock (ORKA) is a publicly traded Healthcare sector company. As of May 21, 2026, ORKA trades at $60.67 with a market cap of $3.52B and a P/E ratio of 0.00. ORKA moved +5.49% today. Year to date, ORKA is +125.71%; over the trailing twelve months it is +471.28%. Its 52-week range spans $5.49 to $91.00. Analyst consensus is strong buy with an average price target of $137.25. Rallies surfaces ORKA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ORKA SEC filings?

Rallies organizes ORKA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ORKA Key Metrics

Key financial metrics for ORKA
Metric	Value
Price	$60.67
Market Cap	$3.52B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$91.00
52-Week Low	$5.49
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-105.43M
Gross Margin	0.00%

Latest ORKA News

Oruka Reports 63.5% PASI 100 Rate and Raises $700M Cash — May 13, 2026
Oruka Therapeutics Prices $700.4M Offer at $72.50 Per Share — Apr 29, 2026
Oruka Therapeutics Files $500M Public Offering with $75M Upsize Option — Apr 27, 2026
Orka Shares Climb 18.9% After 63.5% PASI 100 Trial and $160 Target — Apr 27, 2026
Oruka Therapeutics’ ORKA-001 achieves 63.5% complete skin clearance at week 16 — Apr 27, 2026

Recent ORKA Insider Trades

Agarwal Arjun sold 4.19K (~$244.47K) on May 18, 2026.
Agarwal Arjun sold 4.60K (~$272.26K) on May 18, 2026.
Agarwal Arjun sold 800 (~$48.27K) on May 18, 2026.

ORKA Analyst Consensus

13 analysts cover ORKA: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $137.25.

Common questions about ORKA

Where can I find ORKA SEC filings?: Rallies organizes ORKA SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ORKA 10-K and 10-Q filings?: Rallies organizes ORKA SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ORKA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ORKA. It does not provide personalized investment advice.